adlyxinpro.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Disallow: /*?aspxerrorpath= Disallow: /*.aspx Disallow: /sitecore Disallow: /Sitecore Disallow: /system_pages/ Disallow: /*?WT.mc_id= Disallow: /*?dest= | ||
Meta Tags
| Title | Non-Insulin Therapy for T2D Adult Patients | Adlyxin® (lixisenatide) |
| Description | Adlyxin is an injectable prescription medicine that may improve blood sugar (glucose) control in Adlyxin® is a glucagon‐like peptide‐1 (GLP‐1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.247.151.159 |
| Location | Ireland |
Related Websites
| Site | Rank |
More to Explore
adlyxinpro.com Valuation
|
US$1,499,651
Last updated: 2022-12-15 20:50:30
adlyxinpro.com has Semrush global rank of 7,057,847. adlyxinpro.com has an estimated worth of US$ 1,499,651, based on its estimated Ads revenue. adlyxinpro.com receives approximately 173,037 unique visitors each day. Its web server is located in Ireland, with IP address 54.247.151.159. According to SiteAdvisor, adlyxinpro.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,499,651 |
| Daily Ads Revenue | US$1,385 |
| Monthly Ads Revenue | US$41,529 |
| Yearly Ads Revenue | US$498,346 |
| Daily Unique Visitors | 11,536 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| adlyxinpro.com. | A | 900 | IP: 54.247.151.159 |
| adlyxinpro.com. | NS | 900 | NS Record: ns2.sanofi-synthelabo.com. |
| adlyxinpro.com. | NS | 900 | NS Record: ns3.sanofi-synthelabo.com. |
| adlyxinpro.com. | NS | 900 | NS Record: ns4.sanofi-synthelabo.com. |
| adlyxinpro.com. | NS | 900 | NS Record: ns1.sanofi-synthelabo.com. |
HtmlToTextCheckTime:2022-12-15 20:50:30
| Prescribing information Medication Information Patient Site Read Full Important Safety Information For U.S. Healthcare Professionals Only --> For U.S. Healthcare Professionals Only --> Home What is Adlyxin? Prescribing Adlyxin Resources Prescribing information Medication Information Patient Site Adlyxin is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes, when used with diet and exercise. View Savings Program Not an actual doctor. Indications and Limitations of Use for Adlyxin (lixisenatide) injection Adlyxin is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use: Has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis. Not for treatment of type 1 diabetes or |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Sat, 27 Aug 2022 08:51:39 GMT Server: Apache/2.4.48 () Location: https://www.adlyxinpro.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 content-type: text/html; charset=UTF-8 content-length: 25437 server: AmazonS3 last-modified: Wed, 06 Apr 2022 18:04:11 GMT x-amz-version-id: BwCVhcvfnitRU859KIEi9JYPauDQI6Ta date: Sat, 27 Aug 2022 08:51:40 GMT etag: "f071626dfbd8606a40a29b30688e97f6" vary: Accept-Encoding x-cache: RefreshHit from cloudfront via: 1.1 8b82a0c44466382daf259dbb61c8f23c.cloudfront.net (CloudFront) x-amz-cf-pop: ARN1-C1 x-amz-cf-id: -E70VjdBwwsjkNtbc0poDUSEi8sgDEwl-g5wwR7SOgSIfCL9LzwbVg== |
adlyxinpro.com Whois Information
Domain Name: ADLYXINPRO.COM Registry Domain ID: 2019072975_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2022-04-01T05:16:49Z Creation Date: 2016-04-05T08:49:02Z Registry Expiry Date: 2024-04-05T08:49:02Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.SANOFI-SYNTHELABO.COM Name Server: NS2.SANOFI-SYNTHELABO.COM Name Server: NS3.SANOFI-SYNTHELABO.COM Name Server: NS4.SANOFI-SYNTHELABO.COM DNSSEC: unsigned >>> Last update of whois database: 2022-08-27T08:54:16Z <<< |